SteelPeak Wealth’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $50.5K | Hold |
69,000
| – | – | ﹤0.01% | 495 |
|
2025
Q1 | $55.7K | Hold |
69,000
| – | – | ﹤0.01% | 475 |
|
2024
Q4 | $95.2K | Hold |
69,000
| – | – | ﹤0.01% | 465 |
|
2024
Q3 | $71.8K | Hold |
69,000
| – | – | ﹤0.01% | 446 |
|
2024
Q2 | $119K | Hold |
69,000
| – | – | 0.01% | 437 |
|
2024
Q1 | $165K | Hold |
69,000
| – | – | 0.01% | 410 |
|
2023
Q4 | $230K | Buy |
69,000
+15,000
| +28% | +$50K | 0.01% | 354 |
|
2023
Q3 | $202K | Buy |
54,000
+12,000
| +29% | +$44.9K | 0.01% | 371 |
|
2023
Q2 | $179K | Buy |
42,000
+21,000
| +100% | +$89.7K | 0.01% | 375 |
|
2023
Q1 | $144K | Buy |
21,000
+5,000
| +31% | +$34.2K | 0.01% | 343 |
|
2022
Q4 | $127K | Buy |
+16,000
| New | +$127K | 0.01% | 376 |
|